During the past decade, Site 540: Penyakit Infeksi Sulianti Saroso Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital" are "HIV" (1 trials) and "Infectious Disease" (1 trials). Many other conditions were trialed in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital" in a lesser frequency.

The vast majority of trials in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Site 540: Penyakit Infeksi Sulianti Saroso Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Site 540: Penyakit Infeksi Sulianti Saroso Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Site 540: Penyakit Infeksi Sulianti Saroso Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".